For comparison, treatment of RA with Humira – which requires regular injections – costs around $60,000 a year. Humira is starting to feel the effects of lower-cost biosimilar competition in ...

As pharmaphorum recently reported, the entrance of biosimilars to Humira is a significant event ... aiming to cut injection volume by half and result in fewer injections in particular patients.

Representative Jefferson Shreve (R-Indiana) recently bought shares of AbbVie Inc. (NYSE:ABBV). In a filing disclosed on March ...

AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...

FRANKFURT (Reuters) -Ford will inject up to 4.4 billion euros ($4.8 billion) into its struggling German operations as it tries to revive its European business, the U.S. carmaker said on Monday.

The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...

When giving gluteal injections, it is safest to use the upper outer quadrant. The choice of site for injection must be based on good clinical judgment, using the best evidence available and ...

Although more research is needed in pediatric patients, biosimilars could improve treatment access and reduce costs.

Celltrion and Formycon with Fresenius Kabi launched their respective ustekinumab biosimilars (Steqeyma and Otulfi), joining 4 ...